Expression of SARS-CoV-2 entry molecules ACE2, NRP1, TMPRSS2, and FURIN in the reproductive tissues of male macaques
Ryutaro Moriyama1, Sho Nakamura2,3, Ikki Mitsui2
1Department of Life Science, Kindai University, Higashiosaka, Osaka, 577-8502, Japan. mory@life.kindai.ac.jp.
Abstract:
Coronavirus disease 2019 (COVID-19) reportedly affects male reproductive function by causing spermatogenesis dysfunction and suppressing testosterone secretion. However, the relationship between COVID-19 and impaired reproductive function, such as whether these effects on reproductive function are a direct effect of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in male reproductive organs or an indirect effect of high fever, is not known. Here, we examined whether the cell entry molecules of SARS-CoV-2, namely, ACE2, NRP1, TMPRSS2, and FURIN, are expressed in the male reproductive organs using the testes and accessory gonads of macaques during the breeding season. RT-PCR expression analysis showed that the testes alone expressed all four molecules. Immunohistochemical staining of testis tissue sections revealed that ACE2 is expressed in Leydig cells and the apical region of Sertoli cells, whereas NRP1 is expressed in the cell bodies surrounding the Leydig and Sertoli cell nuclei. FURIN is mainly expressed in Leydig cells, secondary spermatocytes, and spermatids. However, TMPRSS2 immunopositive cells were not observed. Therefore, it was not possible to observe cells expressing all four molecules in the gonads and accessory gonads of male primates. These results suggest that SARS-CoV-2 is unlikely to directly affect spermatogenesis in primates or proliferate in cells of the seminiferous tubules and undergo release into the semen through the previously known ACE2-mediated infection route. However, the expression of three molecules, including ACE2, was observed in Leydig cells, suggesting that testosterone synthesis and secretion may be affected when primates, including humans, are infected with SARS-CoV-2.
Insights
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) may not directly impact primate spermatogenesis. However, its presence in Leydig cells suggests potential effects on testosterone production in males infected with COVID-19.
Area of Science:
- Reproductive biology
- Virology
- Endocrinology
Background:
- Coronavirus disease 2019 (COVID-19) is linked to male reproductive dysfunction, including impaired spermatogenesis and reduced testosterone.
- The direct or indirect mechanisms of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) on male reproductive health remain unclear.
Purpose of the Study:
- To investigate the expression of SARS-CoV-2 cell entry molecules (ACE2, NRP1, TMPRSS2, FURIN) in primate male reproductive organs.
- To determine if SARS-CoV-2 can directly infect male reproductive tissues and affect spermatogenesis or testosterone production.
Main Methods:
- RT-PCR analysis of testes and accessory gonads in macaques to detect gene expression of ACE2, NRP1, TMPRSS2, and FURIN.
- Immunohistochemical staining of macaque testis tissue to localize the expression of these molecules in specific cell types.
Main Results:
- All four SARS-CoV-2 cell entry molecules were detected in macaque testes, but not all in the same cells.
- ACE2, NRP1, and FURIN were found in Leydig cells, Sertoli cells, and germ cells, while TMPRSS2 was not observed.
- The co-expression of all four molecules, necessary for direct viral entry and replication via the known pathway, was not found in primate gonads.
Conclusions:
- SARS-CoV-2 is unlikely to directly infect primate seminiferous tubules and impair spermatogenesis through the ACE2-mediated route.
- The expression of ACE2, NRP1, and FURIN in Leydig cells suggests a potential impact of SARS-CoV-2 infection on testosterone synthesis and secretion in male primates.
More Related Videos
06:25Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Published on: December 23, 2016
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
